MorphoSys AG (MOR.HM)
Hamburg - Hamburg Delayed price. Currency in EUR
Add to watchlist
At close: 08:16AM CEST
| Previous close | 67.85 |
| Open | 67.90 |
| Bid | 67.80 x 0 |
| Ask | 67.95 x 0 |
| Day's range | 67.90 - 67.90 |
| 52-week range | 15.48 - 70.00 |
| Volume | |
| Avg. volume | 129 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Biogen's (BIIB) acquisition of private biotech, HI-Bio, is set to expand its rare disease pipeline by adding the latter's lead asset, felzartamab.
- Simply Wall St.
MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
- Zacks
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
© 2024 Yahoo. All rights reserved.